BTRC
F-box/WD repeat-containing protein 1A
Also known as: beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBW1A_HUMAN, FBXW1A, Fwd1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y297
- Gene
- BTRC
- Ensembl
- ENSG00000166167
- Chromosome
- 10
- Canonical length
- 605 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbws class; in addition to an F-box, this protein contains multiple WD-40 repeats. The encoded protein mediates degradation of CD4 via its interaction with HIV-1 Vpu. It has also been shown to ubiquitinate phosphorylated NFKBIA (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha), targeting it for degradation and thus activating nuclear factor kappa-B. Alternatively spliced transcript variants have been described. A related pseudogene exists in chromosome 6. [provided by RefSeq, Mar 2012]
Canonical amino-acid sequenceUniProt
605 residues, UniProt reviewed canonical sequence.
>Q9Y297|BTRC
1 MDPAEAVLQE KALKFMCSMP RSLWLGCSSL ADSMPSLRCL YNPGTGALTA FQNSSEREDC
61 NNGEPPRKII PEKNSLRQTY NSCARLCLNQ ETVCLASTAM KTENCVAKTK LANGTSSMIV
121 PKQRKLSASY EKEKELCVKY FEQWSESDQV EFVEHLISQM CHYQHGHINS YLKPMLQRDF
181 ITALPARGLD HIAENILSYL DAKSLCAAEL VCKEWYRVTS DGMLWKKLIE RMVRTDSLWR
241 GLAERRGWGQ YLFKNKPPDG NAPPNSFYRA LYPKIIQDIE TIESNWRCGR HSLQRIHCRS
301 ETSKGVYCLQ YDDQKIVSGL RDNTIKIWDK NTLECKRILT GHTGSVLCLQ YDERVIITGS
361 SDSTVRVWDV NTGEMLNTLI HHCEAVLHLR FNNGMMVTCS KDRSIAVWDM ASPTDITLRR
421 VLVGHRAAVN VVDFDDKYIV SASGDRTIKV WNTSTCEFVR TLNGHKRGIA CLQYRDRLVV
481 SGSSDNTIRL WDIECGACLR VLEGHEELVR CIRFDNKRIV SGAYDGKIKV WDLVAALDPR
541 APAGTLCLRT LVEHSGRVFR LQFDEFQIVS SSHDDTILIW DFLNDPAAQA EPPRSPSRTY
601 TYISRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BTRC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- retina: 20 nTPM
- cerebral cortex: 19 nTPM
- basal ganglia: 18 nTPM
- hypothalamus: 14 nTPM
- heart muscle: 14 nTPM
- testis: 13 nTPM
Single-cell type
- sertoli cells: 395 nCPM
- choroid plexus epithelial cells: 336 nCPM
- oligodendrocyte progenitor cells: 294 nCPM
- myonuclei: 291 nCPM
- somatotrophs: 272 nCPM
- thyrotrophs: 269 nCPM
Immune cell
- naive CD4 T-cell: 3.4 nTPM
- memory CD4 T-cell: 3 nTPM
- gdT-cell: 2.9 nTPM
- MAIT T-cell: 2.8 nTPM
- naive CD8 T-cell: 2.8 nTPM
- T-reg: 2.8 nTPM
Brain region
- basal ganglia: 46 nTPM
- cerebral cortex: 46 nTPM
- hypothalamus: 41 nTPM
- hippocampal formation: 39 nTPM
- amygdala: 36 nTPM
- pons: 36 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 2.49
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- branching involved in mammary gland duct morphogenesis
- mammary gland epithelial cell proliferation
- negative regulation of smoothened signaling pathway
- negative regulation of T cell receptor signaling pathway
- negative regulation of transcription by RNA polymerase II
- non-canonical NF-kappaB signal transduction
- positive regulation of circadian rhythm
- positive regulation of DNA-templated transcription
- positive regulation of proteolysis
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein dephosphorylation
- protein destabilization
- protein K48-linked ubiquitination
- protein polyubiquitination
- protein ubiquitination
- regulation of canonical NF-kappaB signal transduction
- regulation of canonical Wnt signaling pathway
- regulation of cell cycle
- regulation of circadian rhythm
- regulation of proteasomal protein catabolic process
- rhythmic process
- SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
- signal transduction
- ubiquitin-dependent protein catabolic process
- Wnt signaling pathway
Molecular functions
- beta-catenin binding
- ligase activity
- protein dimerization activity
- protein phosphorylated amino acid binding
- ubiquitin ligase activator activity
- ubiquitin protein ligase activity
- ubiquitin-like ligase-substrate adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- WD40 repeat
- F-box domain
- WD40/YVTN repeat-like-containing domain superfamily
- WD40 repeat, conserved site
- PAC1/LIS1-like, WD-40 repeat
- D domain of beta-TrCP
- F-box-like domain superfamily
- WD40-repeat-containing domain superfamily
- WD repeat and F-box domain-containing protein
- WD domain, G-beta repeat
- D domain of beta-TrCP
- F-box-like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BTRC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BTRC as an antibody target. Whether an autoantibody or antibody against BTRC could matter depends on whether native BTRC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BTRC is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BTRC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...